APA (7th ed.) Citation

Wenzel, M., Steuber, T., Siech, C., Kriegmair, M., Hoeh, B., Tilki, D., . . . Mandel, P. (2025). Ultralow prostate-specific antigen nadir after apalutamide: Outcomes in synchronous vrsus metachronous metastatic hormone-sensitive prostate cancer. European urology open science, 77, . https://doi.org/10.1016/j.euros.2025.05.001

Chicago Style (17th ed.) Citation

Wenzel, Mike, Thomas Steuber, Carolin Siech, Maximilian Kriegmair, Benedikt Hoeh, Derya Tilki, Axel S. Merseburger, Felix K. H. Chun, and Philipp Mandel. "Ultralow Prostate-specific Antigen Nadir After Apalutamide: Outcomes in Synchronous Vrsus Metachronous Metastatic Hormone-sensitive Prostate Cancer." European Urology Open Science 77 (2025). https://doi.org/10.1016/j.euros.2025.05.001.

MLA (9th ed.) Citation

Wenzel, Mike, et al. "Ultralow Prostate-specific Antigen Nadir After Apalutamide: Outcomes in Synchronous Vrsus Metachronous Metastatic Hormone-sensitive Prostate Cancer." European Urology Open Science, vol. 77, 2025, https://doi.org/10.1016/j.euros.2025.05.001.